Food and Drug Administration nominee Dr. Marty Makary is known for his contrarian views and fiery criticism of traditional medical institutions.

Impatient with years of inaction in Washington on prescription drug prices, U.S. hospital groups, startups and nonprofits have started making their own medicines.

The Food and Drug Administration has approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer's drug.